Introduction {#sec1-1}
============

*Toxoplasma gondii (T. gondii)* is an obligate intracellular protozoan parasite that causes infections in warm blooded animals including humans \[[@ref1]\]. Infections with *T. gondii* in man are commonly asymptomatic or cause mild symptoms that are self-limited \[[@ref2]\]. Symptoms of *T. gondii* infection include malaise, lethargy, and lymphadenitis \[[@ref3]\]. Immunocompromised patients may experience more severe clinical manifestations of toxoplasmosis including chorioretinitis, splenomegaly, encephalitis, pneumonitis, and multisystem organ failure \[[@ref3], [@ref4]\]. Primary infection with *T. gondii* during pregnancy may have serious consequences for the fetus, i.e., miscarriage, central nervous system involvement, or eye disease \[[@ref5]\]. Infection with *T. gondii* may be acquired by ingestion of tissue cysts or tachyzoites contained in meat, or ingestion of environmental sporulated oocysts in contaminated food or water \[[@ref6]\]. In addition, infection with *T. gondii* may occur by blood transfusion \[[@ref7]\] and organ transplantation \[[@ref8], [@ref9]\].

Very little is known about the association between *T. gondii* infection and having a history of surgery. Patients undergoing surgery may be at risk for infection with *T. gondii* if they receive blood transfusions or organ transplants from *T. gondii-*infected donors. However, the magnitude of this association is largely unknown. The presence of tissue cysts in organs and tachyzoites in blood from *T. gondii*-infected donors are involved in the parasite transmission to seronegative recipients. It is unclear whether *T. gondii* can be transmitted by surgical procedures other than organ transplant. It is also unknown whether the use of contaminated materials during surgery might be involved in the transmission of *T. gondii* infection. Surgery has been linked to infection with *T. gondii* in several studies. A positive association between infection with *T. gondii* and a history of surgery was found in psychiatric patients \[[@ref10]\], women with a history of stillbirths \[[@ref11]\], and people applying for medical certificates \[[@ref12]\] in Durango City, Mexico. It is unclear whether the association found in these population groups was influenced by any factor. There is a need to confirm or challenge such association using a case--control study design. To the best of our knowledge, no previous case--control study about the association between infection with *T. gondii* and a history of surgery has been reported. Therefore, this study aimed to determine the association between seropositivity to *T. gondii* and a history of surgery of people in Durango City, Mexico.

Materials and Methods {#sec1-2}
=====================

Study Design {#sec2-1}
------------

We performed an age- and gender-matched case--control seroprevalence study of 391 subjects with (cases) and 391 subjects without (controls) a history of surgery. This study was performed from January 2015 to May 2018 in Durango City, Mexico.

Subjects Studied {#sec2-2}
----------------

Subjects with a history of surgery were enrolled in 4 public health care centers in Durango City, Mexico: the family care center of the Institute of Security and Social Services of State Workers, the Health Care Center No. 2 and the psychiatric hospital \"Dr. Miguel Vallebueno\" of the Secretary of Health, and the municipal Clinic of Sanitary Inspection. Selection of participants was carried out by using a simple random sampling. Inclusion criteria for the cases were as follows: a) having a history of surgery, b) 13 years and older, c) any gender, and d) who voluntarily participate in the study. Cases were 13--78 (mean = 36.56 ± 11.3) years old and included 45 males (11.5%) and 346 (88.5%) females. Number of surgeries, type of surgery, organ or tissue operated, and surgery specialties were recorded from each case. Inclusion criteria for the controls were: a) no having a history of surgery, b) 13 years and older, c) any gender, and d) who voluntarily participate in the study. Controls were subjects randomly selected from the general population in Durango City and were matched with cases by gender, age, birthplace (Durango State, Mexico), and urban residence (Durango City). Controls included 45 males (11.5%) and 346 females (88.5%) aged 13--78 (mean = 36.56 ± 11.3) years old, and their age was not different from that in cases *(P* = 1.00).

Detection of Anti-T. Gondii Immunoglobulin G (IgG) and M (IgM) Antibodies {#sec2-3}
-------------------------------------------------------------------------

A serum sample from each case and control was examined for the presence of anti*-T. gondii* IgG and IgM antibodies. Anti*-T. gondii* IgG antibodies was detected with the commercially available enzyme immunoassay kit *\"Toxoplasma* IgG\" (Diagnostic Automation Inc., Woodland Hills, CA, USA). This test allowed the quantification of anti*-T. gondii* IgG antibody in International Units (IU)/mL. A cutoff ≥ 8 IU/mL was used for seropositivity as indicated in the kit\'s insert. Serum samples positive for anti-*T. gondii* IgG antibodies were further analyzed for anti*-T. gondii* IgM antibodies by the commercially available enzyme immunoassay *\"Toxoplasma* IgM\" kit (Diagnostic Automation Inc.), following the instructions of the manufacturer.

Statistical Analysis {#sec2-4}
--------------------

The statistical analysis of data was performed with the software Epi Info version 7 (Centers for Disease Control and Prevention: <http://wwwn.cdc.gov/epiinfo/>) and SPSS version 15.0 (SPSS Inc. Chicago, Illinois). We calculated the sample size using the following data: a 95% confidence level, a power of 80%, a 1:1 proportion of cases and controls, a reference seroprevalence of 6.1% \[[@ref13]\] as the expected frequency of exposure in controls, and an odds ratio (OR) of 2.1. The result of the sample size calculation was 370 cases and 370 controls. The student\'s *t* test was used to compare the age of cases and controls. We determined the association between *T. gondii* seropositivity and surgery data with the Pearson\'s chi-square test. We determined the association between *T. gondii* seropositivity and surgery variables with *P* values ≤0.20 obtained in the bivariate analysis using logistic regression analysis with the Enter method. OR and 95% confidence intervals (CI) were calculated. A *P* value less than 0.05 was considered as statistically significant.

Ethics Aspects {#sec2-5}
--------------

This project was approved by the Ethics Committee of the General Hospital of the Secretary of Health in Durango City, Mexico. All participants received information about the purpose and procedures of this study, and a written informed consent to participate in the study was obtained from each of them.

Results {#sec1-3}
=======

Anti*-T. gondii* IgG antibodies were found in 25 (6.4%) of the 391 cases and in 21 (5.4%) of the 391 controls (OR = 1.29; 95% CI: 0.66--2.18; *P* = 0.54). Stratification by age and gender showed no difference (*P* \> 0.05) in the seroprevalence of *T. gondii* infection between cases and controls ([Table 1](#table001){ref-type="table"}). Of the 25 anti*-T. gondii* IgG positive cases, 10 (40.0%) had anti-*T. gondii* IgG antibody levels higher than 150 IU/mL, 3 (12.0%) between 100 IU/mL and 150 IU/mL, and 12 (48.0%) between 8 to 99 IU/mL. In contrast, of the 21 anti*-T. gondii* IgG positive controls, 8 (38.1%) had anti*-T. gondii* IgG antibody levels higher than 150 IU/mL, 2 (9.5%) between 100 IU/mL and 150 IU/mL and 11 (52.4%) between 8 to 99 IU/mL. The frequency of subjects with high IgG antibody levels in cases was equal to that found in controls (OR = 1.08; 95% CI: 0.32--3.56; *P* = 0.89).

Of the 25 anti*-T. gondii* IgG antibody seropositive cases, 5 (16.0%) were also positive for anti*-T. gondii* IgM antibodies. Meanwhile, of the 21 anti*-T. gondii* IgG antibody seropositive controls, 4 (19.0%) were also positive for anti*-T. gondii* IgM antibodies. No difference in the rate of IgM seropositivity between cases and controls was found (OR = 0.81; 95% CI: 0.17--3.72; *P* = 0.80).

Concerning the number of surgeries, cases had had between 1 to 6 surgeries. The seroprevalence of *T. gondii* infection did not vary *(P* = 0.75) with the number of surgeries: 6.0% in subjects with one surgery, 8.1% in those with 2 surgeries, and 5.6% in those with 3 or more surgeries.

Bivariate analysis showed no association between *T. gondii* seropositivity and the type of surgery ([Table 2](#table002){ref-type="table"}), or organ, tissue, or region operated ([Table 3](#table003){ref-type="table"}). Only the variables \"hysterectomy\", \"salpingectomy\", and \"fallopian tubes\" showed a *P* value of ≤0.20. Meanwhile, bivariate analysis of the *T. gondii* seropositivity rate and surgical specialties showed two variables with a *P* value of ≤0.20: general surgery and orthopedic surgery ([Table 4](#table004){ref-type="table"}).

Further analysis by logistic regression of variables that obtained a *P* value of ≤0.20 in the bivariate analysis (hysterectomy, general surgery, and orthopedic surgery) showed that only the variable \"hysterectomy\" was associated with *T. gondii* seropositivity (OR = 4.6; 95% CI: 1.6--13.4; *P* = 0.005). The variables \"salpingectomy\" and \"fallopian tubes\" were not included in the regression analysis, because no seropositive cases with these characteristics were found (zero values in the cells).

Discussion {#sec2-6}
----------

The epidemiological link between infection with *T. gondii* and surgical procedures has been scantily studied. We are not aware of any age- and gender-matched case control study on the association between *T. gondii* infection and a history of surgery. In this study, we not only aimed to determine this association using an age- and gender-matching but also took matching by birthplace and residency into consideration. This strategy provided a more stringent study design. In several epidemiological studies on *T. gondii* infection in Durango, Mexico, we have observed that people born in Mexican states other than Durango had a higher seroprevalence of *T. gondii* infection than those born in Durango State \[[@ref12]\]. In addition, people living in rural Durango \[[@ref15]\] had a higher seroprevalence of *T. gondii* infection than those residing in the urban Durango City \[[@ref13]\]. We found similar frequencies of anti*-T. gondii* IgG and IgM antibodies in cases to those found in controls. In addition, stratification by age and gender groups showed no difference in the IgG and IgM seroprevalence between cases and controls. Similarly, the frequency of high (\>150 IU/mL) anti*-T. gondii* antibody levels in cases was equal to that found in controls. The results thus suggest that there was no association between seropositivity to *T. gondii* and a history of surgery in the people studied. This finding was unexpected because several studies in our region have found an association between seropositivity to *T. gondii* and a history of surgery. In Durango City, we found a positive association between *T. gondii* infection and a history of surgery in psychiatric patients \[[@ref10]\], women with a history of stillbirths \[[@ref11]\], and people applying for medical certificates \[[@ref12]\]. Similarly, *T. gondii* infection was associated with a history of hernia repair \[[@ref16]\]. In addition, in a study of Yoremes, an ethnic group in the northwestern Mexican State of Sonora, we found that *T. gondii* exposure was associated with a history of cesarean sections in the women surveyed \[[@ref17]\]. The reason for the association between seropositivity to *T. gondii* and a history of surgery was found in previous studies but not in the present study could be explained by the difference in the aims, number of cases, and research methods among the studies. Firstly, in the present study the main aim was to determine the association between *T. gondii* infection and a history of surgery, whereas this association was assessed as a secondary aim in the studies in psychiatric patients \[[@ref10]\], women with a history of stillbirths \[[@ref11]\], and people applying for medical certificates \[[@ref12]\]. This fact is important because control of variables (age, gender, etc.) is focused predominantly in reaching the main aim rather than secondary aims. Secondly, in the present study, we studied 391 cases, whereas the number of cases was low in previous studies, i.e., 55 cases were analyzed in the study of hernia repair \[[@ref16]\], 95 in women with a history of stillbirths \[[@ref11]\], 23 in Yoremes \[[@ref17]\], and 193 in people applying for medical certificates \[[@ref12]\]. Thirdly, the research method used in the present study is more stringent for assessing an association that those used in previous studies. In the previous studies, no matching by birthplace and residency was used, whereas in the present study we did.

In the current study, we found that seropositivity to *T. gondii* was associated with a history of hysterectomy. We are not aware of any report about this association. It is unclear why the frequency of infection with *T. gondii* was higher in women with hysterectomy than their age- and gender-matched controls. It is possible that infection of uterus with *T. gondii* may lead to disease of this organ that eventually might lead to hysterectomy. It is known that *T. gondii* infects nearly any nucleated cell, and after infection, spreads to a large variety of organs in the body \[[@ref18]\]. Therefore, the uterus may be involved in *T. gondii* infection. In fact, tachyzoite and DNA of *T. gondii* were observed in uterus of mice after experimental vaginal infection \[[@ref19]\]. Numerous intra-epithelial tachyzoites of *T. gondii* were found in a Hector\'s dolphin (*Cephalorhynchus hectori)* with a marked suppurative metritis \[[@ref20]\]. In addition, in experimental infections with *T. gondii* in mice, researchers found accentuated hypertrophy of the endometrium and myometrium \[[@ref21]\]. Research to confirm the association between seropositivity to *T. gondii* and hysterectomy and to determine the role of *T. gondii* infection on uterus pathology in women is needed.

This study was limited by the fact that the association between *T. gondii* infection and a history of surgery was determined in subjects with only some types of surgeries, and few cases in certain surgeries were studied.

Conclusions {#sec1-4}
===========

Results of this first age- and gender-matched case--control study about the association between *T. gondii* infection and surgery suggest that having a history of surgery is not an important risk factor for infection with *T. gondii.* However, the link between *T. gondii* infection and a history of hysterectomy found should be further investigated.
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###### 

Comparison of seropositivity rate to *T. gondii* according to sex and age between cases and controls

  Characteristic    Cases   Controls   *P* value                    
  ----------------- ------- ---------- ----------- ----- ---- ----- ------
  Sex                                                               
  Male              45      2          4.4         45    2    4.4   1.0
  Female            346     23         6.6         346   19   5.5   0.52
  Age (years old)                                                   
  30 or less        132     11         8.3         132   6    4.5   0.21
  31--50            203     11         5.4         203   12   5.9   0.83
  \>50              56      3          5.4         56    3    5.4   1.0

###### 

Correlation of *T. gondii* seroprevalence and types of surgery

  Type of surgery in cases   Cases   Controls   Cases vs controls\*                     
  -------------------------- ------- ---------- --------------------- ----- ---- ------ ------
  Appendectomy               44      3          6.8                   44    2    4.5    1.00
  Braquioplasty              4       1          25.0                  4     0    0.0    1.00
  Cesarean section           167     9          5.4                   167   10   6.0    0.81
  Cholecystectomy            41      4          9.8                   41    1    2.4    0.35
  Cyst removal               9       0          0.0                   9     1    11.1   1.00
  Fat removal                3       0          0.0                   3     0    0.0    --
  Hernia repair              15      2          13.3                  15    1    6.7    1.00
  Hysterectomy               22      5          22.7                  22    1    4.5    0.18
  Knee arthroscopy           11      1          14.3                  11    0    0.0    1.00
  Mammoplasty                4       1          25.0                  4     0    0.0    1.00
  Maxillofacial surgery      5       0          0.0                   5     0    0.0    --
  Nephrectomy                5       0          0.0                   5     0    0.0    --
  Osteoplasty                17      1          5.9                   17    0    0.0    1.00
  Periodontal surgery        69      4          5.8                   69    3    4.3    1.00
  Phlebectomy                3       0          0.0                   3     0    0.0    --
  Refractive eye surgery     11      1          9.1                   11    1    9.1    1.00
  Rhinoplasty                4       0          0.0                   4     0    0.0    --
  Salpingectomy              57      0          0.0                   57    5    8.8    0.05
  Salpingo-oophorectomy      4       1          25.0                  4     1    25.0   1.00
  Tissue removal             3       0          0.0                   3     0    0.0    --
  Tonsillectomy              16      0          0.0                   16    0    0.0    --
  Uterine curettage          16      0          0.0                   16    0    0.0    --

###### 

Correlation of *T. gondii* seroprevalence and organ, tissue or anatomical region of surgery

  Organ, tissue or region operated in cases   Cases   Controls   Cases vs controls[\*](#tfn001){ref-type="table-fn"}                     
  ------------------------------------------- ------- ---------- ----------------------------------------------------- ----- ---- ------ ------
  Abdominal cavity                            22      2          9.1                                                   22    1    4.5    1.00
  Appendix                                    43      3          7.0                                                   43    2    4.7    1.00
  Arm                                         4       1          25.0                                                  4     0    0.0    1.00
  Blood vessels                               3       0          0.0                                                   3     0    0.0    --
  Bones                                       16      1          6.3                                                   16    0    0.0    1.00
  Breast                                      5       1          20.0                                                  5     0    0.0    1.00
  Eyes                                        6       0          0.0                                                   6     1    16.7   1.00
  Fallopian tubes                             58      0          0.0                                                   58    5    8.6    0.05
  Fingers                                     3       0          0.0                                                   3     0    0.0    --
  Gallbladder                                 41      4          9.8                                                   41    1    2.4    0.35
  Intestine                                   3       0          0.0                                                   3     0    0.0    --
  Joint                                       9       1          11.1                                                  9     0    0.0    1.00
  Kidney                                      7       0          0.0                                                   7     0    0.0    --
  Maxillary                                   5       0          0.0                                                   5     0    0.0    --
  Nose                                        5       0          0.0                                                   5     0    0.0    --
  Ovary                                       5       1          20.0                                                  5     1    20.0   1.00
  Retina                                      6       1          16.7                                                  6     0    0.0    1.00
  Teeth                                       70      4          5.7                                                   70    3    4.3    1.00
  Tonsils                                     16      0          0.0                                                   16    0    0.0    --
  Uterus                                      188     13         6.9                                                   188   11   5.9    0.67

\*Matched by age and sex.

###### 

Correlation of *T. gondii* seroprevalence and surgical specialties

  Specialty that attended cases   Cases   Control   Cases vs control^[a](#tfn002){ref-type="table-fn"}^                     
  ------------------------------- ------- --------- ----------------------------------------------------- ----- ---- ------ ------
  Angiology                       4       0         0.0                                                   4     0    0.0    --
  General surgery                 105     9         8.6                                                   105   4    3.8    0.15
  Plastic surgery                 8       1         12.5                                                  8     1    12.5   1.00
  Obstetrics and gynecology       236     14        5.9                                                   236   16   6.8    0.70
  Thoracic surgery                4       0         0.0                                                   4     0    0.0    --
  Odontology                      73      4         5.5                                                   73    3    4.1    1.00
  Ophthalmology                   12      1         8.3                                                   12    1    8.3    1.00
  Orthopedic surgery              35      4         11.4                                                  35    0    0.0    0.11
  Otorhinolaryngology             18      0         0.0                                                   18    0    0.0    --
  Urology                         11      0         0.0                                                   11    0    0      --

^a^Matched by age and sex.
